Comorbidities Worsen Carpal Tunnel Outcomes
Patients with systemic diseases had worse symptoms and function before and following surgery, though improvement after release was similar.
By
Julie Greenbaum
March 17, 2026
Clinical Scorecard: Comorbidities Worsen Carpal Tunnel Outcomes
At a Glance
Category Detail
Condition Carpal Tunnel Syndrome Key Mechanisms Systemic diseases may contribute to nerve compression through inflammatory changes, neuropathic effects, and tissue swelling. Target Population Adults aged 18 to 64 with or without systemic diseases. Care Setting Single-center study at Van Yuzuncu Yil University Hospital, Turkey.
Key Highlights
Patients with systemic diseases had worse symptoms and functional limitations pre- and post-surgery. Both groups showed similar degrees of improvement after carpal tunnel release. Systemic diseases evaluated included rheumatoid arthritis, diabetes mellitus, hypothyroidism, obesity, and hypertension. Guideline-Based Recommendations
Diagnosis
Utilize the Boston Carpal Tunnel Questionnaire (BCTQ) for symptom and functional assessment. Management
Consider carpal tunnel release surgery for patients with systemic diseases despite worse baseline symptoms. Monitoring & Follow-up
Assess symptom severity and functional capacity pre- and postoperatively. Risks
Higher body mass index may confound outcomes in patients with systemic diseases. Patient & Prescribing Data
Adults with carpal tunnel syndrome, including those with systemic diseases.
Surgery provides similar therapeutic efficacy regardless of comorbidity status.
Clinical Best Practices
Match patients for age and sex to reduce confounding factors. Evaluate and address potential confounding factors such as body mass index. Related Resources & Content
